Disrupting the transmembrane domain interface between PMP22 and MPZ causes peripheral neuropathy

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Peripheral myelin protein 22 (PMP22) and MPZ are key Schwann cell myelin proteins.
• Alterations in PMP22 and MPZ cause demyelinating peripheral neuropathies, including Charcot-Marie-Tooth disease (CMT).
• The precise molecular functions of PMP22 and mechanisms underlying CMT remain unclear.

Purpose of the Study:

• To elucidate the molecular interaction between PMP22 and MPZ.
• To investigate the functional consequences of PMP22 mutations on this interaction.
• To define the structural basis of PMP22-MPZ complex formation.

Main Methods:

• Co-immunoprecipitation assays to detect protein complex formation.
• Analysis of PMP22 variants, including the A67T mutation, using cell-based assays.
• Cellular localization studies to assess protein trafficking and membrane association.

Main Results:

• MPZ and PMP22 form a specific complex mediated by their transmembrane domains.
• The PMP22 A67T patient variant, associated with hereditary neuropathy with pressure palsies, disrupts MPZ binding.
• This PMP22 variant does not affect its plasma membrane localization or interactions with other proteins.

Conclusions:

• The MPZ-PMP22 complex is formed through specific interfaces within their transmembrane regions.
• Disruption of the MPZ-PMP22 interaction by PMP22 variants underlies certain peripheral neuropathies.
• This interaction is critical for normal myelin function in Schwann cells.